NCT04570280

Brief Summary

It is aimed to objectively demonstrate and compare the effectiveness of aerobic and resistant exercises performed on female patients with rheumatoid arthritis with sonographic muscle measurements. In addition, it is planned to compare the effects of 2 group exercises on functional status, quality of life and body composition and to show its correlation with sonographic measurements. There are 3 groups in total in the study. These are the control group given only the range of motion exercise, the second group given the range of motion and resistance exercise, and the third group given the range of motion and aerobic exercise. Exercise programs will last 12 weeks and it is planned to exercise 3 days a week.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P25-P50 for not_applicable rheumatoid-arthritis

Timeline
Completed

Started Dec 2020

Shorter than P25 for not_applicable rheumatoid-arthritis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 14, 2020

Completed
16 days until next milestone

First Posted

Study publicly available on registry

September 30, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

December 1, 2020

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2021

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2021

Completed
Last Updated

December 15, 2022

Status Verified

December 1, 2022

Enrollment Period

10 months

First QC Date

September 14, 2020

Last Update Submit

December 14, 2022

Conditions

Keywords

Rheumatoid ArthritisExercise TherapyExercise

Outcome Measures

Primary Outcomes (12)

  • Ultrasonographic Muscle Size Measurement

    Ultrasonographic measurements of transverse muscle thickness will be made in M. Rectus femoris, vastus intermedius, long head of M. biceps femoris and medial head of M. Gastrocnemius. Ultrasonographic measurements will be made at the midpoint between the anterior superior iliac spina and the upper end of the patella for rectus femoris and vastus intermedialis. For the medial head of the gascrokinemius, the measurement will be made at the thickest point where the head of the muscle is in the leg area, and for the biceps femoris muscle, 60% distal between the greater trochanter and the outer femoral condyle and at the intersection point of a line drawn at the midline of the popliteal fossa. While measurements made for rectus femoris and vastus intermedius were evaluated in the supine position; The biceps femoris and gastrocnemius will be evaluated while the patient lies comfortably in the prone position.

    at 12th week

  • 5 chair test

    In the 5 chair test used in evaluating the functional status of the patient, "The practitioner allows the patient to sit on the chair with his back. The time it takes to sit and get up 5 times is measured with a stopwatch. " It will be made as.

    at 12th week

  • Timed up and go test

    In the timed get up and walk test, "3 meters of space is determined in front of the patient sitting on a chair. The patient is asked to get up from the chair, walk this distance and sit down again. Elapsed time is measured with a stopwatch. " It will be applied as.

    at 12th week

  • 6-minute walking test

    In the 6-minute walking test, "The patient's goal should be to walk the longest distance that he can walk within 6 minutes. The longest distance that the patient can walk after 6 minutes is calculated in meters.

    at 12th week

  • International Physical Activity Scale

    Those who score HIGH on the IPAQ engage in * Vigorous intensity activity on at least 3 days achieving a minimum total physical activity of at least 1500 MET minutes a week OR * 7 or more days of any combination of walking, moderate intensity or vigorous intensity activities achieving a minimum total physical activity of at least 3000 MET minutes a week. Scoring a MODERATE level of physical activity on the IPAQ means * 3 or more days of vigorous intensity activity and/or walking of at least 30 minutes per day OR * 5 or more days of moderate intensity activity and/or walking of at least 30 minutes per day OR * 5 or more days of any combination of walking, moderate intensity or vigorous intensity activities achieving a minimum total physical activity of at least 600 MET minutes a week. Scoring a LOW level of physical activity on the IPAQ means that you are not meeting any of the criteria for either MODERATE of HIGH levels of physical activity.

    at 12th week

  • Body Composition Measurements - Muscle

    In body composition measurements measured with the DEXA device, total muscle (kg) and their ratio to the total body will be calculated.

    at 12th week

  • Body Composition Measurements - Fat

    In body composition measurements measured with the DEXA device, total fat mass according to regions (kg) and their ratio to the total body will be calculated.

    at 12th week

  • Body Composition Measurements - Soft tissue

    In body composition measurements measured with the DEXA device, total soft tissue mass (kg) and their ratio to the total body will be calculated.

    at 12th week

  • Short Form - 36

    In the evaluation with the short form-36, it is aimed to learn the patient's views about her own health, how she feels and how much she can perform her daily activities. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.

    at 12th week

  • Visual Pain Scale

    Visual pain scale scored from 0 (no pain) to 10 (maximal pain) will be used in the global pain assessment of the patient.

    at 12th week

  • Fear assessment questionnaire in inflammatory rheumatic diseases

    Fear assessment questionnaire in inflammatory rheumatic diseases will be filled. Minimum value is 0, maximum value is 100. Higher score is worse result

    at 12th week

  • Body mass index

    Body mass index (weight and height will be combined to report BMI in kg/m\^2) will be calculated.

    at 12th week

Study Arms (3)

Range of Motion Exercises

PLACEBO COMPARATOR

The patients in the control group will be given the practice of range of motion exercises for 12 weeks, 3 days a week for 50 minutes (1 day accompanied by a physiotherapist).

Other: Range of Motion Exercises

Range of Motion and Resistive Exercises Group

ACTIVE COMPARATOR

Patients in this group will be given joint range of motion and resistive exercises with sandbag to the lower extremity for 12 weeks, 3 days a week for 50 minutes (1 day in the presence of a physiotherapist). For the exercises with resistance, the repetition maximum will be calculated and the intensity of the exercises will be adjusted in accordance with the DeLorme protocol.

Other: Resistive ExercisesOther: Range of Motion Exercises

Range of Motion and Aerobic Exercises Group

ACTIVE COMPARATOR

Joint range of motion exercises and aerobic exercises on the treadmill will be given to the aerobic exercise arm, 3 days a week for 12 weeks (1 day in the presence of a physiotherapist). For aerobic exercises, the maximum heart rate of the patients will be calculated during exercise and the exercise intensity will be determined by increasing the target heart rate level during the exercise.

Other: Aerobic ExercisesOther: Range of Motion Exercises

Interventions

Resistive exercises with sandbag will be applied 3 times a week for 12 weeks.

Range of Motion and Resistive Exercises Group

Aerobic exercises with treadmill will be applied 3 times a week for 12 weeks.

Range of Motion and Aerobic Exercises Group

Range of Motion Exercises will be applied 3 times a week for 12 weeks.

Range of Motion ExercisesRange of Motion and Aerobic Exercises GroupRange of Motion and Resistive Exercises Group

Eligibility Criteria

Age20 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Romatoid Arthritis diagnosed for\> 1 year
  • Female gender
  • The patient has been in remission or low disease activity for at least 3 months
  • years

You may not qualify if:

  • Patient with active arthritis or high disease activity
  • Significant deformity and inability to ambulate in the lower extremity joints
  • Pregnant patient
  • Patient with menopause
  • The presence of malignancy
  • A patient with a serious psychiatric disorder and difficulty in cooperation
  • Presence of cardiovascular and pulmonary comorbidity that may prevent exercise
  • Male gender

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Health Sciences, Şişli Hamidiye Etfal Training and Research Hospital

Istanbul, Turkey (Türkiye)

Location

Related Publications (1)

  • Ayyildiz A, Yilmaz F, Altindas H, Ciftci S, Kuran B. Effects of Aerobic and Resistive Exercise on Muscle Measurements and Body Composition in Female Patients With Rheumatoid Arthritis. Am J Phys Med Rehabil. 2023 Dec 1;102(12):1076-1084. doi: 10.1097/PHM.0000000000002283. Epub 2023 May 10.

MeSH Terms

Conditions

Arthritis, RheumatoidMotor Activity

Interventions

ExerciseRange of Motion, Articular

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaPhysical ExaminationDiagnostic Techniques and ProceduresDiagnosis

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

September 14, 2020

First Posted

September 30, 2020

Study Start

December 1, 2020

Primary Completion

September 30, 2021

Study Completion

October 10, 2021

Last Updated

December 15, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations